3 Reasons Royalty Pharma Is a Dividend Stock You Never Have to Sell
Healthcare isn’t optional, which makes the pharmaceutical sector fairly resilient through the entire economic cycle. Royalty Pharma (RPRX +1.80%) has created a diversified portfolio of royalties on drugs that are approved for sale and on drugs that are still in development. For buy-and-hold income investors, this unique healthcare stock could be the perfect way to…